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 Synthesis, Diastereomer Separation, Optoelectronic and Structural 
Properties of Dinuclear Cyclometalated Iridium(III) Complexes with 
Bridging Diarylhydrazide Ligands  
Daniel G. Congrave, Yu-ting Hsu, Andrei S. Batsanov, Andrew Beeby and Martin R. Bryce*  
Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, UK 
 
ABSTRACT: A series of diiridium complexes 13–16 bridged by diarylhydrazine ligands and cyclometalated by phenylpyridine or 
phenylpyrazole ligands was synthesized. In all cases the ɅΔ meso and ɅɅ/ΔΔ rac diastereomers were separated and characterized 
by single-crystal X-ray diffraction, revealing intramolecular – stacking between arenes of the bridging and cyclometalating lig-
ands. Density functional theory (DFT) calculations show that in general the HOMOs are mainly localized on the iridium centers, 
the cyclometalating phenyl moieties and the central hydrazide components of the bridging ligands, while the LUMOs are primarily 
localized on the N-heterocycles (pyridine or pyrazole) of the cyclometalating ligands.  This series of complexes, especially with the 
separated diastereomers, provides an ideal opportunity to study the effects of subtle structural changes on the optoelectronic proper-
ties of diiridium systems: significant differences are observed between the rac and meso isomers in some cases. A cyclic voltam-
metric study of the electrochemical properties of the eight complexes reveals strong intramolecular interactions between the iridium 
centers. The photophysical properties are reported in solution, and in rigid poly(methyl methacrylate) (PMMA) or 2-
methyltetrahydrofuran (2-MeTHF) (at 77 K) matrices where some of the complexes are strongly emissive in the turquoise and 
green regions (ΦPL 42–68 ±10%) due to matrix-induced restricted intramolecular motion (RIM).
INTRODUCTION 
Luminescent Ir(III) complexes have been widely employed in a 
diverse range of applications,1 such as photocatalysis,2 biological 
labelling2–4 and sensing.5 Moreover, they have received particular 
attention as phosphorescent emitters in organic light-emitting 
devices (OLEDs) and light-emitting electrochemical cells 
(LECs),6,7 where heavy atom induced spin-orbit coupling theoret-
ically enables the harvesting of all electro-generated excitons. 
Such complexes exhibit a range of favorable properties, such as 
high quantum efficiency (Φ), rather short phosphorescence life-
times (τp), reversible electrochemistry and synthetic versatility, 
while being sufficiently robust to often withstand thermal evapo-
ration as a means of device fabrication.2,8,9 Cyclometalated Ir(III) 
complexes feature metal-ligand-based luminescent properties and 
high energy non-emissive metal-centered (MC) states, which 
enables broad color tuning through structural variation.8  
Cyclometalated diiridium complexes are frequently encoun-
tered in the form of μ-dichloro-bridged dimers, which were first 
reported in 1974 by Nonoyama10 and are usually synthesized ac-
cording to Watts’ procedure.11 Such complexes have found wide-
spread use as precursors to cyclometalated heteroleptic and homo-
leptic monoiridium complexes.12,13 However, μ-dichloro-bridged 
dimers are generally poorly emissive14,15 (apart from a few recent 
exceptions16,17), a feature common to many diiridium systems, 
e.g. 1, 2 and 3 (Figure 1).18–29 Consequently, for luminescence 
applications research has primarily concentrated on monoiridium 
complexes.30,31 
Nevertheless, the study of phosphorescent diiridium complexes 
is a rapidly expanding topic and a range of complexes with vari-
ous conjugated bridging ligands have been reported to possess 
efficient photo- (PL) and electroluminescence (EL).32–37 Impres-
sive solution photoluminescence quantum yields (PLQYs) of up 
to 100% have been reported by Williams, Kozhevnikov and co-
workers (compound 4),36,38 while solution-processed OLEDs with 
external quantum efficiencies (EQEs) of >10% have been report-
ed by our group (complex 5)39 and also the groups of Zhou and 
Wong (complex 6).40 
  
Figure 1. Representative diiridium complexes from the literature. 
 
These examples demonstrate that correctly designed diiridium 
complexes can overcome the limitation of poor luminescence and 
present a feasible alternative to typical monoiridium systems.38  
An important feature of the bridging ligands within diiridium 
complexes is that they provide an increased potential for structural 
variation compared to monoiridium systems.37,41–43 Bimetallic 
complexes also present a number of other potential advantages, 
such as increased spin-orbit coupling due to the presence of mul-
tiple metal centers (which may lead to an increase in the radiative 
rate constant (kr)), easier access to efficient red emitters due to 
conjugated bridging units,36,38 higher stability due to the improved 
chelating effect of a bridging ligand, and the possibility of dual 
emission.  
To obtain high efficiency phosphorescence, it is important to 
limit non-radiative deactivation (quantified by the non-radiative 
rate constant (knr)) of the excited complex and this has been 
achieved through rigidification of the phosphor.44–46 In diiridium 
complexes, which incorporate conjugated bridging ligands, theo-
retical calculations often predict that a degree of frontier orbital 
character is localized on the bridging unit.23,26,29,32,35,37–40,42 In 
these cases a highly flexible bridge is expected to promote non-
radiative processes and weaken emission. Consequently, the ma-
jority of the reported diiridium complexes that possess high solu-
tion state PLQYs incorporate rigid bridging units (such as com-
pounds 4 and 6).32,36–37 Highly emissive complexes featuring flex-
ible bridges are rare: for example, compound 2 shows aggregation 
induced emission (AIE) but is otherwise non-emissive.35  
The aim of the present work is to explore the potential of dia-
rylhydrazide bridging ligands, which we first introduced in an 
initial communication on complex 5.39 An interesting design fea-
ture of these bridges is that they provide a short conjugative path-
way between the two Ir centers. We now present a series of new 
diiridium complexes (13–16) featuring different cyclometalated 
ligands. In all cases the diastereomers have been separated and 
characterized by their single-crystal X-ray structures. The electro-
chemical properties of the complexes have been studied in solu-
tion, and the photophysical properties are reported in solution, 
rigid poly(methyl methacrylate) (PMMA) or 2-
methyltetrahydrofuran (2-MeTHF) (77 K) matrices, where some 
of them are strongly emissive. Density functional theory (DFT) 
calculations provide further insights into the photophysical prop-
erties.
  
  
Figure 2. General synthetic scheme and structures of the diiridium complexes 13–16, a = ɅΔ meso diastereomers b = ɅɅ/ΔΔ rac 
diastereomers, studied in this work. 
SYNTHESIS  
To synthesize the target diiridium complexes 13–16 the cyclomet-
alating ligands 7–10 were firstly refluxed with IrCl3•3H2O in 2-
ethoxyethanol to generate the corresponding μ-dichloro-bridged 
intermediate complexes in situ (Figure 2). The intermediate com-
plexes were subsequently cleaved with the hydrazide bridging 
ligands 11 or 12 in the presence of K2CO3 to obtain the diiridium 
complexes 13–16. Due to the chiral nature of the iridium centers 
mixtures of meso(ɅΔ, a) and rac (ΔΔ/ɅɅ, b) diastereomers were 
obtained for all of the complexes, as is commonly observed for 
cyclometalated diiridium complexes featuring Ir–Ir distances 
greater than ca. 5 Å.23,26,27,32,34,40,47 (It is noteworthy that with 
[Ir(ppy)2µ–Cl]2-type complexes where the Ir–Ir distances are <4 
Å only the less sterically congested rac ΔΔ/ɅɅ diastereomers 
have been reported to date15–18,39,48–55). For 13–16 the diastere-
omers were separated by fractional crystallization, silica column 
chromatography, or a combination of the two techniques. Alt-
hough stable in methylene chloride (DCM) solution, some of the 
complexes partially decomposed on silica columns to form small 
amounts of μ-dichloro-bridged dimers when DCM was used as 
the eluent. Displacement of non-cyclometalated ligands to form μ-
dichloro dimers in the presence of a chloride source in acidic me-
dia has been previously reported.56 This problem was overcome in 
the present work by the use of K2CO3-saturated DCM during 
purification. The high level of diastereomeric excess of the sam-
ples was confirmed by 700 MHz 1H NMR spectra (as demonstrat-
ed for 14a and b in Figure 3 and for the other complexes in Fig-
ures S4, S7, S28, S35, S42 and S46). A notable feature is the 
presence of highly-shielded aromatic protons in the 4.8–5.5 ppm 
region for all complexes 13–16. This upfield shift is consistent 
with intramolecular  stacking in the complexes, as observed in 
the X-ray crystal structures (see below). Additional NMR spectra 
(where solubility allowed) including 1H–1H COSY, 1H–1H 
NOESY, 1H–13C HSQC and 1H–13C HMBC data are shown in the 
SI.   
Figure 3. Aromatic regions from the 700 MHz 1H NMR spectra of 14a (top) and 14b (bottom) in CDCl3. * = residual CHCl3 from CDCl3, 
# = CH2Cl2. An inseparable trace amount of 14b is observed in the spectrum of 14a.
 COMPUTATIONAL STUDY 
 
Figure 4. Molecular orbital compositions for complex 13a. 
  
The optimized ground state S0 geometries were calculated at 
the B3LYP/LANL2DZ:3–21G* level with the LANL2DZ 
pseudopotential for the iridium atoms and the 3–21G* basis 
set for other atoms. These data are, therefore, directly compa-
rable to previous computational studies on Ir(ppy)3 and other 
diiridium complexes.16,39 As a general trend in the optimized 
geometries, the central bridge CNNC dihedral angle is calcu-
lated to be planar (180º) for the meso (a) isomers, whereas it 
is twisted for the rac (b) isomers and displays greater varia-
tion between complexes (144–156º). This is ascribed to the 
greater steric restriction encountered in the meso isomers 
which forces the bridging units to adopt more planar confor-
mations. A similar trend is also observed experimentally in 
the X-ray crystal structures discussed below. 
 Molecular orbital calculations were carried out to deter-
mine the distribution of the frontier molecular orbitals 
(FMOs). The FMO compositions of 13a are shown in Figure 
4 as a representative example and the data for all the com-
plexes 13–16 are summarized in Table S3. (FMO plots for all 
other complexes are shown in Figures S70–S76). In general, 
except for 13b where the bridge also features notable LUMO 
character, the HOMOs are mainly localized on the iridium 
centers, the cyclometalating phenyl moieties and the central 
hydrazide components of the bridging ligands, while the 
LUMOs are primarily localized on the N-heterocycles of the 
cyclometalating ligands. These data are in good agreement 
with the literature compound 5 (Figure 1).39 To the best of 
our knowledge complexes 13 and 14 are the first heteroleptic 
iridium complexes for which there is significant LUMO lo-
calization on the pyrazole groups of the cyclometalating lig-
ands 7 and 8.57–59 This is indicative of the high π* energy of 
the bridge 11. 
 The high contribution of the bridge to the HOMO levels 
of the complexes (non-ancillary character) indicates that the 
bridging units should play a significant role in the first oxida-
tion potentials of the complexes and also in their excited 
states. This is in agreement with the electrochemical and 
photophysical data discussed below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
X-RAY CRYSTALLOGRAPHIC STUDIES 
 
 
Table 1. Selected geometrical parameters of diiridium complexes (bond distances in Å). 
 13a 13b 14a 14b a 14b b 15a c 15a d 15b 16a e 16a f 16b 
Space 
group 
P21/c P21/c P ̅ P ̅ P21/n P ̅ P21/c Pbcn P ̅ P ̅ C2/c 
Mol.  
symmetry 
Ci -- Ci -- -- Ci Ci C2 Ci Ci C2 
Ir centers ɅΔ ɅɅ or 
ΔΔ 
ɅΔ ɅɅ or 
ΔΔ 
ɅɅ or 
ΔΔ 
ɅΔ ɅΔ ɅɅ or 
ΔΔ 
ɅΔ ɅΔ ɅɅ or 
ΔΔ 
Ir…Ir 5.013 5.031 4.988 5.007 5.031 5.00 5.029 5.089 5.035, 
5.063 
5.047 5.095 
Ir–C 
(trans-O) 
1.992(4) 2.006(6) 2.023(5) 2.000(5) 2.007(4)  1.997(2) 1.996(3) 1.994(3) 1.990(1) 2.000(2) 
Ir–C 
(trans-N) 
2.004(3) 1.994(6) 2.011(5) 2.003(5) 2.008(4)  1.989(2) 1.998(3) 2.005(3) 1.997(1) 2.006(2) 
Ir–N, 
stacked 
2.011(3) 2.005(6) 2.009(5) 2.013(5) 2.015(3)  2.027(2) 2.025(3) 2.027(2) 2.028(1) 2.032(2) 
Ir–N, non-
stacked 
2.018(3) 1.973(6) 2.014(5) 2.018(4) 2.004(3)  2.044(2) 2.032(3) 2.051(2) 2.045(1) 2.044(2) 
Bridge geometry 
OCNNCO   
folding, ° 
planar 23.9 planar 13.6, 
20.8 
21.0 planar planar 29.5 planar planar 9.8 
Ir 
displace-
ment, Å 
0.60 0.18 0.06 0.06, 
0.16 
0.16 0.59 0.57 0.43 0.46, 
0.33 
0.46 0.10 
Ir–O 2.144(3) 2.116(4) 2.102(4) 2.112(4) 2.111(3)  2.154(1) 2.123(2) 2.143(2) 2.154(1) 2.144(1) 
Ir–N 2.152(3) 2.156(5) 2.134(4) 2.144(4) 2.160(3)  2.155(2) 2.181(2) 2.164(2) 2.162(1) 2.174(1) 
N–N 1.436(6) 1.439(7) 1.441(8) 1.444(6) 1.447(4)  1.442(3) 1.459(5) 1.444(4) 1.434(2) 1.440(3) 
N–C 1.307(5) 1.324(8) 1.308(6) 1.308(6) 1.306(5)  1.315(2) 1.313(4) 1.308(3) 1.316(1) 1.313(2) 
C–O 1.295(4) 1.292(8) 1.295(6) 1.286(6) 1.288(4)  1.288(2) 1.285(4) 1.283(3) 1.280(1) 1.281(2) 
Intramolecular stacking (π–π) 
Θ, ºg 22.1 12.3, 
20.3 
12.2 20.6, 
27.2, 
16.5, 
15.3  
11.9, 9.4 22 12.0 15.5 7.2, 8.2 6.6 7.6 
D, Åh 3.52 3.35, 
3.57 
3.26 3.64, 
3.66, 
3.47, 
3.47 
3.39, 
3.42 
3.54 3.40 3.40 3.43, 
3.36 
3.39 3.36 
a 14b·DCM, average of two independent molecules; b 14b·2DCM·½C6H14, 
c 15a·4DCM, major component (bond distances are unreliable 
due to all-molecule disorder); d 15a·1.84MeOH·0.16DCM; e 16a·½CD2Cl2, average of two independent molecules; 
f 16a·2CD2Cl2; 
g inter-
planar angle between the cyclometalating ligand and arene ring A of the bridging ligand (see 14a, Figure 5); h distance between the cy-
clometalating ligand plane and the centroid of ring A 
The molecular structures of complexes 13–16 were studied by 
single-crystal X-ray crystallography. Important parameters are 
summarized in Table 1. All structures except 14a and 16b (Figure 
5) contain solvent of crystallization, which is usually disordered.  
In all meso (a) complexes, the molecule is rigorously centro-
symmetric, i.e. lies on a crystallographic inversion center (at the 
midpoint of the N–N bond) which relates the two Ir centers. The 
rac (b) (ɅɅ or ΔΔ) isomers either lie on a crystallographic two-
fold axis, or have no crystallographic symmetry, but the crystal is 
always centrosymmetric and hence racemic. In each case, both Ir 
atoms have distorted octahedral coordination, involving one N 
and one O atom of the bridge, and two C^N cyclometalating lig-
ands arranged with their coordinating N atoms trans and axial, as 
expected.9,39 Complex 14b was studied in two different solvates 
(Figures S53 and S54), one of the structures containing two sym-
metrically independent molecules, and the same applies to 16a 
(Figures S58 and S59). In each case, different crystal packing 
facilitates relatively minor changes in the molecular confor-
mations and practically no differences in the bond distances. 
In all meso (a) complexes the central bridging hydrazide 
(OCNNCO) moiety is planar (notably in accurate agreement with 
the aforementioned geometry optimized DFT structures) with the 
 two Ir atoms tilting from their planes in opposite directions by 
0.3–0.6 Å (except 14a where they are almost coplanar). In rac (b) 
forms, the bridge is folded along the N–N bond (again in good 
agreement with DFT): the two OCNN planes form an angle of 10 
to 30°, whereas the Ir atoms deviate from these planes less than in 
meso (a) forms (by 0.1–0.4 Å).   
In each complex, either aryl substituent of the bridging ligand is 
stacked face-to-face (–) with a cyclometalating ligand (Figure 
5). Ring A overlaps mainly with the phenyl ring (B) of the latter, 
although in most structures (especially strongly in 15b) it is shift-
ed towards the pyridyl or pyrazole ring in a quasi-graphitic fash-
ion, whereas in 13b, 14a and 14b·DCM, ring A slips in the oppo-
site direction (Figures S62 and S63). The interplanar angles (Θ) of 
6.6–27.2 º and mean separations (D) of 3.26–3.66 Å between the 
overlapping moieties (Table 1) are common for arene stacking. 
These are rare examples of intramolecular π–π interactions be-
tween bridging and peripheral ligands. Indeed, we are not aware 
of any previous examples in cyclometalated diiridium systems, 
although intramolecular – interactions have been studied in 
neutral60 and cationic monoiridium complexes.57,61,62 
 
 
 
Figure 5. X-ray molecular structures of 14a, 14b, 16a and 16b. Thermal ellipsoids are drawn at the 50% probability level, H atoms are 
omitted for clarity. Primed atoms are generated by a crystallographic inversion center (14a, 16a) or a twofold axis (16b). Vector D identi-
fies intramolecular – interactions (see Table 1).  
 
ELECTROCHEMICAL AND PHOTOPHYSICAL 
STUDIES 
 
The oxidation potentials of the diiridium complexes 13–16 
were obtained by cyclic voltammetry (CV) (Figure 6) and are 
listed in Table 2. All complexes display two oxidation waves 
which are assigned to sequential oxidation of the iridium 
atoms (Ir3+/ Ir4+ redox couples) and also indicate electronic 
coupling between the two centers through the bridging units. 
The trend in the first oxidation potentials is 14 > 16 > 15 > 
13. This is in line with the strength of the electron withdraw-
ing substituents on the phenyl rings of the cyclometalating 
ligands and also correlates with the DFT predictions (above) 
that the bridge phenyl moieties do not possess HOMO char-
acter. This reduces the effect of the strongly withdrawing 
CF3 groups on the oxidation potentials of 16a and 16b. As a 
general trend, DFT calculations overestimate the HOMO 
energies of the diiridium complexes compared to the experi-
mental values (Table 2). Reduction processes were not ob-
served down to ca. –2.5 V vs. FcH/FcH+ (Representative 
voltammograms for complexes 13b and 15b are presented in 
Figures S67 + S68). 
 An interesting feature of the CV data is that significantly 
different oxidation potentials are reproducibly observed for 
both species 13a and 13b, in particular for the first oxidation 
process (ΔE1/2 for E
ox(1) = 60 mV). When a 1:1 mixture was 
analyzed (Table 2) intermediary oxidation potentials were 
observed compared to the diastereomerically pure samples, 
although the oxidation processes for each diastereomer could 
not be resolved by differential pulse voltammetry (Figure 
S69). There is also a significant difference in the oxidation 
potentials between the two diastereomers 14a and 14b.  
 The differences in the electrochemical properties of the 
diastereomers is ascribed to the different molecular symme-
 tries of the complexes (meso a = Ci, rac b = C2) and the fact 
that diastereomers are known to commonly exhibit differing 
physical properties. A similar difference between the oxida-
tion potentials of diiridium diastereomers has been previous-
ly reported for complex 6.40 Large differences in the CNNC 
dihedral angles of the bridges for the optimized geometries 
of the diastereomers (see above) could also be related to 
some of the observed differences in electrochemical proper-
ties between isomers. 
 For the phenylpyridine complexes 15 and 16 the peak 
splittings (ΔE1/2) (Table 2) between the two oxidation pro-
cesses are smaller than for the phenylpyrazole analogs 13 
and 14, in line with the calculated lower HOMO contribu-
tions from the bridges of 15 and 16 (Table S3). The lowest 
ΔE1/2 values (ca. 250 mV vs. >400 mV for all other complex-
es) are observed for complexes 16a and b, as expected from 
the functionalization of the bridge 12 with strongly electron-
withdrawing CF3 groups which results in lower bridge 
HOMO contributions (Table S3). The electrochemical prop-
erties of the diastereomers of the phenylpyridine-
functionalized complexes 15 and 16 are very similar.      
 
Figure 6. Cyclic voltammograms in 0.1 M n-Bu4NPF6/ DCM 
showing the oxidation processes for 13–16.  
 
Table 2.Oxidation potentials for the Ir3+/ Ir4+ couples (Eox, V) of compounds 13–16 referenced to FcH/ FcH+ = 0.00 V. E1/2 values are quot-
ed for electrochemically reversible oxidations. 
a HOMO levels calculated from CV potentials by HOMO = –4.8 + (–E1/2
ox(1)), using ferrocene as the standard. b Frontier orbital energies 
calculated from optimized geometries at B3LYP/LANL2DZ:3–21G* level. 
 
  
Complex Isomer 
Eox(1) /V 
Epa/ Epc
  [E1/2 ] 
Eox(2) /V 
Epa /Epc [E1/2] 
ΔE1/2 /V HOMO /eV
a 
HOMO 
/eVb 
LUMO 
/eVb 
13 
a meso 0.29/ 0.21 [0.25] 
0.78/ 0.69 
[0.73] 
0.48 –5.05 –4.55 –0.84 
b rac 0.23/ 0.15 [0.19] 
0.82/ 0.73 
[0.77] 
0.58 –4.99 –4.52 –0.89 
a + b 1:1 
mix 
0.27/ 0.17 [0.22] 
0.81/ 0.72 
[0.76] 
0.54 –5.02 - - 
14 
a meso 0.67/ 0.57 1.11/ 0.96 0.41 –5.42 –5.09 –1.16 
b rac 0.55/ 0.44 [0.49] 
1.08/ 0.97 
[1.03] 
0.54 –5.29 –5.05 –1.10 
15 
a meso 0.42/ 0.34 [0.38] 0.84/ 0.72 0.40 –5.18 –4.62 –1.26 
b rac 0.42/ 0.34 [0.38] 0.88/ 0.76 0.44 –5.18 –4.82 –1.36 
16 
a meso 0.57/ 0.46 [0.52] 
0.82/ 0.71 
[0.77] 
0.25 –5.32 –5.01 –1.63 
b rac 0.55/ 0.46 [0.51] 
0.82/ 0.71 
[0.77] 
0.26 –5.31 –5.04 –1.62 
 The absorption and emission spectra for the diiridium complex-
es are shown in Figures 7–9 and S64–66 and the key data are 
listed in Table 3. For the phenylpyrazole complexes 13 and 14, 
the bands in the absorption spectra (Figure S64, Table 3) in the 
230–270 nm region are ascribed to spin-allowed ligand-centered 
(LC) 1π–π* transitions, while the longer wavelength bands which 
extend to 400 nm are assigned to both singlet and triplet metal-to-
ligand charge transfer states (1MLCT and 3MLCT) following 
literature precedents.13 Such high energy onsets of absorption (ca. 
420 and 380 nm) indicate high triplet energies (ET) of ca. 3.0 and 
3.3 eV for 13 and 14, respectively.  For the phenylpyridine com-
plexes 15 and 16 similar assignments apply to the absorption 
spectra (Figure 7, Table 3): 1π–π* 250–350 nm, 1MLCT and 
3MLCT 350–500 nm.13,63  
Figure 7. Absorption spectra of complexes 15 and 16 rec-
orded in room temperature DCM solutions. Inset: expansions 
of the 360–480 nm regions of the spectra. 
 
Photoluminescence could not be detected for the phenylpyra-
zole complexes 13 and 14 at room temperature in DCM solutions 
(Table 3). This can be explained by considering thermal popula-
tion of low-lying non-emissive MC excited states at room temper-
ature.64 This is promoted by the inadequate crystal field strength 
of the ligands, which combined with the high ET values of the 
complexes leads to d–d* gaps (MC energies) comparable to the 
MLCT energies. This explanation has been previously suggested 
for non-emissive homoleptic phenylpyrazole complexes,65 which 
like 13 and 14 are predicted to feature significant LUMO contri-
bution from electron rich pyrazole moieties and  have large ET 
values. 
In room temperature DCM solutions, complexes 15 (Figure 
S65) and 16 are poorly emissive in the turquoise and green re-
gions (ΦPL <1% and nanosecond-scale lifetimes) (Table 3), which 
is ascribed to facile non-radiative deactivation of their excited 
states. This is evidenced by their non-radiative rate constants (knr) 
(Table 3) which are exceptionally high (e.g. 8.3 × 108 s–1 for 16a 
and b), even in comparison to knr for [Ir(ppy)2µ-Cl]2 (8.0 × 10
6 s–
1)17 - a diiridium complex commonly known to be poorly emissive 
(PLQY = 0.5% in toluene, 0.1% in DCM).14,17 
When doped into poly(methyl methacrylate) (PMMA) (Figure 
8), the PLQYs increase by 2–3 orders of magnitude for complexes 
15  and 16, respectively, with observed microsecond-scale life-
times (Table 3). This is due to the comparable decreases in the 
values of knr for the complexes (by 2–3 orders of magnitude) ra-
ther than increases in the values of kr, which are on the order of 
105 s–1 for 15 and 16 in both DCM and PMMA (comparable to 
Ir(ppy)3  kr = 2.1 × 10
5 s–1).13 
As the cyclometalating ligands in 15 and 16 have been previ-
ously incorporated into complexes that are highly emissive in 
solution13,66 it can be concluded that the bridging ligands play a 
significant role in the photophysical properties of the complexes 
in the present study (in agreement with the DFT and electrochem-
istry data above) and are most likely responsible for their matrix-
dependent behavior. In room temperature DCM solutions the 
highly flexible bridges facilitate non-radiative decay via intramo-
lecular motion which quenches the emission. When the complexes 
are doped into rigid PMMA matrices, this property is suppressed 
leading to large increases in PLQY. Moreover, neat films of com-
plexes 15 and 16 drop-cast from DCM solutions were found to be 
non-emissive (presumably due to triplet–triplet annihilation),67,68 
strengthening our conclusion that this phenomenon occurs in 
PMMA due to matrix-induced restricted intramolecular motion 
(RIM), rather than an intermolecular interaction between the 
diiridium complexes.  
Functionalization with electron-withdrawing groups of the cy-
clometalating or bridging ligands in complexes 15 and 16, respec-
tively, each lead to hypsochromic shifts in emission wavelength 
compared to the literature compound 5 (Figure 1) (λmax  PL = 521/ 
523 nm).39 These observations indicate that variation of either the 
bridging or cyclometalating ligands can be used to tune the color 
of this diiridium system.  
Figure 8. Normalized emission spectra of complexes 15 and 
16 doped into PMMA at 1% wt. λexc = 355 nm. 
 
Emission spectra (Figure S66) recorded in 2-MeTHF at 77 K 
for complexes 15 and 16 show lifetimes increased to the micro-
second-scale due to the expected reduction in vibrations (Table 3). 
Well-resolved vibronic structures at this temperature may also be 
indicative of a high LC contribution to their excited states.69 With-
in experimental error there is no significant variation in PL prop-
erties between the diastereomers for 15 and 16.  
Our explanation regarding the non-emissive properties of com-
plexes 13 and 14 is reinforced by the photophysical data obtained 
in PMMA at room temperature and in 2-MeTHF at 77 K (Table 
3). Doping the complexes into rigid PMMA matrices is insuffi-
cient to prevent non-radiative quenching, and, therefore, we pro-
pose that the non-emissive properties of the complexes are not 
solely due to bridge flexibility. However, cooling the complexes 
down to 77 K alters the Boltzmann distribution and suppresses 
thermal population of the non-radiative MC states,13,65 giving rise 
to emission (Figure 9) with microsecond-scale lifetimes (Table 3). 
At 77 K, other than weak emission at ca. 400–450 nm (which we 
assign to emission from states of LC/ MLCT character)13 broad 
low energy emission bands (450–800 nm) centered at ca. 550 and 
590 nm are also observed for complexes 13/ 14a and 13/ 14b, 
respectively. This emission is reminiscent of that previously re-
ported at room temperature for a heteroleptic phenylimidazole-
functionalized monoiridium complex by Nazeeruddin et al.,70 
where the broad emission was suggested to originate from multi-
ple degenerate emissive states of mixed character. This explana-
 tion may also apply to complexes 13 and 14 which are also het-
eroleptic Ir complexes featuring diazole cyclometalating ligands. 
The wavelength of the broad bands appears to be dependent on 
the stereochemistry of the complexes and almost independent of 
substitution on the phenylpyrazole ligands, indicating that the 
differing molecular symmetry of diiridium diastereomers can have 
a significant influence on their photophysical properties. This 
feature is not generally observed in diiridium complexes21,40 and 
may be related to the higher LUMO level of the pyrazole ligands 
in 13 and 14. 
 
Figure 9. Normalized emission spectra of complexes 13 and 
14 in 2-MeTHF glasses at 77 K. λexc = 355 nm. Inset: photo-
graphs of the emission from 13a (left) and 13b (right) under 
irradiation from a 365 nm UV lamp. The peaks at ~710 nm 
are the second-order diffraction of the scattered excitation 
beam. 
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Table 3. Summary of the key photoluminescence data for compounds 13–16. 
aSolution photoluminescence measurements were recorded in degassed DCM solutions at ca. 20 ºC with an excitation wave-
length of 355 nm with Ir(ppy)3 as standard (Φ = 0.46).
66 Absorption spectra were recorded in aerated acetonitrile for 13 and 14 
and aerated DCM for 15 and 16, sh = shoulder. bMeasured at 77 K using an excitation wavelength of 355 nm. cNon-emissive is 
defined as PLQY <0.03%. dMeasured in an integrating sphere under air using an excitation wavelength of 355 nm. τp = 1/ knr + 
kr. 
 
CONCLUSIONS 
 
In conclusion, we have synthesized four new diarylhydrazide-
bridged diiridium complexes 13–16 for which the diastereomers 
have been separated and their photophysical, electrochemical and 
structural properties studied in detail.  
Significant differences in photophysical and electrochemical 
properties between diastereomers were observed for the phenylpy-
razole-functionalized complexes 13 and 14, whereas this is not the 
case for the phenylpyridine complexes 15 and 16. The emissive 
properties of 15 and 16 were found to drastically improve upon 
doping the complexes into solid PMMA matrices, due to matrix-
induced RIM (PLQY increases of 2–3 orders of magnitude com-
pared with their DCM solutions). DFT calculations have provided 
additional insights into the photophysical properties, and the cal-
culated geometries of the central bridging units are in accurate 
agreement with single-crystal X-ray diffraction data. We also 
present rare examples of intramolecular π–π stacking between the 
bridging and peripheral ligands of a cyclometalated diiridium 
complex. This interesting feature, combined with the scope for 
new structural variations in the cyclometalating ligands and the 
 
Solutiona 
2-MeTHF 
glassb 
Doped into PMMA 1% wt.d 
Complex Isomer 
λabs /nm (ε × 
104 / M–1cm–1) 
λmax 
em 
/nm 
PLQY 
/% (± 
5%) 
τp 
/ns 
kr /× 
105 s–1 
knr /× 
105 s–1 
λmax 
em 
/nm 
τp 
/μs 
λmax 
em 
/nm 
PLQY 
/% (± 
10%) 
τp 
/μs 
kr /× 
105 s–1 
knr /× 
105 s–1 
13 
a meso 
224 (8.79), 
280sh (3.41), 
305 (2.47), 341 
(1.22), 383 
(0.36) 
Non-emissivec 
(421, 
448) 
542 
8.7 
Non-emissivec 
b rac 
234 (8.53), 
281sh (3.75), 
308 (2.21), 344 
(1.20), 383 
(0.36) 
(424, 
443) 
591 
7.7 
14 
a meso 
222 (8.88), 
250sh (6.57), 
260sh (5.59), 
294 (2.49), 326 
(1.34), 364 
(0.26) 
(394, 
414) 
552 
26.2 
b rac 
226 (8.00), 
249sh (6.61), 
295 (2.17), 323 
(1.28), 365 
(0.23) 
(395) 
593 
7.6 
 
15 
a meso 
272 (10.37), 
306 (6.75), 
321sh (5.20), 
399 (1.00), 440 
(0.50), 473 
(0.23) 
489  0.23 34.2 0.58 291.8 479  3.7 493  58 1.5 3.87 2.80 
b rac 
264 (12.00), 
313 (7.73), 393 
(1.45), 445 
(0.64), 474 
(0.33) 
493  0.23 51.8 0.39 192.7 481  3.6 494  68 1.6 4.25 2.00 
16 
a meso 
262 (12.82), 
306sh (5.57), 
350 (2.50), 383 
(1.48), 408 
(1.26), 462 
(0.72), 489 
(0.32) 
514  0.03 1.2 2.50 8331 502  3.7 512  45 1.7 2.65 3.24 
b rac 
260 (11.30), 
306 (5.43), 351 
(2.25), 383 
(1.48), 461 
(0.63) 
513  0.03 1.2 2.50 8331 499  4.4 515  42 1.7 2.47 3.41 
 bridges, should increase the appeal of diiridium complexes as an 
important platform for fundamental studies and for optoelectronic 
applications.  
 
EXPERIMENTAL SECTION 
General  
1
H, 
13
C and 
19
F
 
NMR spectra were recorded on Bruker Avance 
400 MHz, Varian Mercury 200, and 400 MHz, Varian Inova 500 
MHz or Varian VNMRS 600 and 700 MHz spectrometers.  All 
spectra were referenced against the residual solvent signal and 
peak shifts are reported in ppm. For NMR stability experiments 
the samples were prepared in the specified deuterated solvent 
and degassed by three freeze pump thaw cycles, before being 
irradiated at 254 nm with a 6 W UV lamp or refluxed for the 
specified time. Electrospray ionisation (ESI) mass spectra were 
recorded on a Waters Ltd. TQD spectrometer. Atmospheric sol-
ids analysis probe (ASAP) mass spectra were recorded on a LCT 
premier XE spectrometer. Matrix-assisted laser desorption time-
of-flight (MALDI–TOF) mass spectra were recorded on a 
Bruker Daltonik Autoflex II spectrometer running in positive ion 
reflectron mode. MALDI–TOF samples were prepared in 
CH2Cl2 with trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-
propenylidene]malononitrile (DCTB) as the matrix. Elemental 
analyses were obtained on an Exeter Analytical Inc. CE-440 
elemental analyzer. Reactions requiring an inert atmosphere 
were carried out under argon which was first passed through a 
phosphorus pentoxide column. Thin layer chromatography 
(TLC) was carried out on silica gel (Merck, silica gel 60, F254) or 
alumina (Merck, neutral alumina 60 type E, F254) plates and vis-
ualized using UV light (254, 315, 365 nm). Flash chromatog-
raphy was carried out using either glass columns or a Biotage
®
 
Isolera One
TM
 automated flash chromatography machine on 60 
micron silica gel purchased from Fluorochem Ltd. or type WN-6 
neutral activity grade super I alumina purchased from Sigma 
Aldrich Co.  
 
Chemicals 
All commercial chemicals were of ≥95% purity and were used as 
received without further purification. [Ir(ppy)2µ–Cl]2,
11
 N-
phenylpyrazole (7),
71
 N-(2,4-difluorophenyl)pyrazole (8)
71
, 2-(2-
fluoro-4-methoxyphenyl)pyridine (10)
66 
 and N,N’-bis(4-tert-
butylphenylbenzoyl)hydrazide (11)
72
 were all synthesized ac-
cording to literature procedures. All solvents used were of ana-
lytical reagent grade or higher. Anhydrous solvents were dried 
through a HPLC column on an Innovative Technology Inc. sol-
vent purification system. 
 
Calculations 
 
All calculations were carried out with the Gaussian 09 
package.
73
 All optimized S0 geometries of the diiridium com-
plexes were carried out using B3LYP
74,75
 with the pseudopoten-
tial (LANL2DZ)
76–78
 for iridium and 3–21G* basis set for all 
other atoms.
79,80
All S0 geometries were true minima based on no 
imaginary frequencies found. Electronic structure calculations 
were also carried out on the optimized geometries at 
B3LYP/LANL2DZ:3–21G*. The MO diagrams and orbital con-
tributions were generated with the aid of Gabedit
81
 and Gauss-
Sum
82
 packages, respectively. 
 
X-ray Crystallography 
 
Single crystals of all diiridium complexes 13–16 suitable for X-ray 
diffraction (XRD) were grown via slow diffusion of either n-hexane 
or methanol into their near-saturated DCM solutions, other than for 
16a where crystals were obtained via slow evaporation of a CD2Cl2 
solution. Experiments were carried out on a Bruker 3-circle CCD 
diffractometer D8 Venture with a PHOTON 100 CMOS area detector, 
using Mo-Kα radiation (λ=0.71073 Å) from an Incoatec IμS mi-
crosource with focusing mirrors. Crystals were cooled to 120 K using 
a Cryostream 700 (Oxford Cryosystems) open-flow N2 gas cryostat. 
Absorption corrections were performed by numerical integration 
based on measured crystal shape, or (for 13b) by semi-empirical 
method based on Laue equivalents and multiple scans.
83 
The struc-
tures were solved by Patterson (13b, 16a·2CD2Cl2) or direct methods 
using SHELXS software,
84
 and refined by full-matrix least squares 
using SHELXL
85
 and OLEX2 software.
86 
 
Crystallization of 14b from a DCM/hexane solution proceeds in 
two Ostwald stages: a DCM di-solvate is precipitated initially (Figure 
S53), which then re-crystallizes into a mixed DCM-hexane solvate 
(Figure S54). Similarly, crystallization of 15a from a DCM-methanol 
solution, yields first a DCM tetrasolvate (Figure S55) and then a 
methanol di-solvate with a minor substitution of methanol by DCM 
(Figure S56). In the metastable form, a large part of the host molecule 
is disordered, including the Ir atoms, and the abnormally high dis-
placement parameters of the rest also suggest disorder. 13b (Figure 
S51) crystallized as a non-merohedral twin with the twin law (1 0 0 0 
-1 0 -1/3 0 -1), deconvoluted using PLATON TwinRotMatrix pro-
gram.
87
 Structure 14b·DCM (Figure S53) is triclinic (space group 
P ̅); the lattice can be transformed to an apparently C-centred mono-
clinic (a=32.880, b=12.873, c=27.590 Å, α=89.87, β=102.81, 
γ=90.14°) but the atomic structure does not fit this symmetry. Inde-
pendent experiments with three different crystals revealed in each 
case a pseudo-merohedral twinning with the twin law (1 0 0 -1 -1 0 0 
0 -1) corresponding to the (absent) monoclinic twofold axis. The 
contribution of the second species was refined to 0.454, 0.195 and 
0.0558(2), respectively; the latter experiment was used for the final 
refinement. 
 
 
Electrochemistry 
 
Cyclic voltammetry experiments were recorded using a BAS 
CV50W electrochemical analyzer fitted with a three-electrode 
system consisting of a Pt disk (Ø = 1.8 mm) as the working elec-
trode, a Pt wire as an auxiliary electrode and an Pt wire as a qua-
sireference electrode. Cyclic voltammetry experiments were 
conducted at a scan rate of 100 mV/s. Experiments were con-
ducted in either dry DCM or dry 1,2-dimethoxyethane solution 
with n-Bu4NPF6 (0.1 M) as the supporting electrolyte. 
Differential pulse voltammetry experiments were recorded using 
a PalmSens EmStat
2
 potentiostat with PSTrace software. 
Experiments were conducted with step potentials (E step), pulse 
potentials (E pulse) and pulse times (t Pulse) of 5 mV, 100 mV, 
and 0.1 s, respectively, at a scan rate of 10 mV/s. The reference 
electrode was assumed to be stable and was referenced 
externally to ferrocene. 
 
Photophysics 
General The absorption spectra were measured on either a Unicam 
UV2-100 spectrometor operated with the Unicam Vision software or 
a Thermo Scientific Evolution 220 spectrometer with the Thermo 
Scientific Insight software in quartz cuvettes with a path length of 20 
mm. The pure solvent was used for the baseline correction. The ex-
tinction coefficients were calculated using the Beer-Lambert Law, A 
= εcl. The photoluminescence spectra were recorded on a Horiba 
Jobin Yvon SPEX Fluorolog 3-22 spectrofluorometer in quartz cu-
vettes with a path length of 10 mm. All Ir complexes were measured 
in degassed DCM (repeated freeze-pump-thaw cycles using a turbo-
molecular pump). The quantum yields of all samples were determined 
by the comparative method relative to Ir(ppy)3 as a standard (Φ = 0.46 
 in degassed DCM measured in-house vs. quinine sulphate in 0.5 M 
H2SO4 Φ = 0.546
66
) following the literature procedure.
88
 The quantum 
yields of complexes doped into poly(methyl methacrylate) (PMMA) 
thin films were recorded on a Horiba Jobin Yvon SPEX Fluorolog 3-
22 using an integrating sphere and were calculated according to the 
literature method.
89
 Solid state PLQY data were obtained in triplicate 
from three samples that were prepared in parallel: the calculated 
standard error values were ≤10%. Lifetime measurements were rec-
orded using an N2 laser (337 nm, 10 μJ, 10 Hz) as an excitation source 
in a custom spectrometer which produced a 1 kHz train of pulses of 
20 ns duration..  The luminescence was collected at 90° and focused 
onto the entrance slit of a monochromator (Bethan TM 300V).  The 
emission was detected by a photon counting PMT and the arrival 
times of photons at the detector determined using a multichannel 
scaler.  The data were transferred to a PC and analyzed using non-
linear regression. The decay data were fitted to exponential functions. 
Low temperature emission spectra and lifetime data were measured in 
a DN1704 optical cryostat (Oxford Instruments) with a ITC601 tem-
perature controller (Oxford Instruments). 
PMMA film preparation 100 µL of a 1 mg mL
–1
 solution of the 
diiridium complex in DCM was added to 1 mL of a 10 mg mL
–1 
solu-
tion of PMMA in N,N-dimethylformamide (DMF) and the resulting 
solution was stirred open to air at room temperature (ca. 2 h). The 
solution was then drop-cast using a Gilson precision pipette onto a 15 
x 1 mm circular quartz disk (UQG Optics Ltd., UK) in ca. 10 x 50 µL 
portions, allowing the solvent to evaporate at room temperature under 
air in between each addition (ca. 30 min – 1 h). A final 50 µL portion 
was then drop-cast onto the quartz disk before it was heated to ca. 40 
ºC overnight on a hot plate under air. Photophysical analysis was then 
immediately carried out. 
Synthesis 
 
N,Nʹ-Bis(3,5-bis(trifluoromethyl)benzoyl)hydrazide (12). 
Based on a literature procedure for analogs,
90
 3,5-
bis(trifluoromethyl)benzoyl chloride (5.00 g, 18.1 mmol, 2.13 
eq.) was added dropwise under air to a stirred solution of hydra-
zine monohydrate (425 mg, 8.49 mmol, 1.00 eq.) in ethanol (10 
mL), which was cooled in an ice bath to maintain the reaction 
temperature below 15 °C. A white precipitate formed immedi-
ately. Once the addition was half complete, a solution of Na2CO3 
(954 mg, 9.00 mmol, 1.06 eq.) in water (10 mL) was added 
dropwise alongside the remaining 3,5-
bis(trifluoromethyl)benzoyl chloride. After the addition of the 
reagents was completed (ca. 20 min), the ice bath was removed 
and stirring was continued at room temperature for a further 30 
min. The reaction mixture was poured into water (50 mL), al-
lowed to settle for 1 h and filtered to collect crude 12 as a white 
powder (4.35 g, 8.50 mmol, 100%), containing ca. 10 mol% of 
residual mono-acylated intermediate (tentatively identified by 
1
H 
NMR). Analytically pure 12 was obtained via recrystallization 
from 5:1 v/v ethanol/n-hexane mixture (60 mL) as white needles 
(3.91 g, 7.63 mmol, 90%). 
1
H NMR (400 MHz, DMSO-d6) δ 
(ppm) = 11.31 (s, 2H), 8.59 (s, 4H), 8.45 (s, 2H); 
13
C NMR (101 
MHz, DMSO-d6) δ 163.3 (CC=O), 134.7, 131.3 (q, 
2
J = 33.4 Hz, 
Cquart), 128.8, 126.3, 123.5 (q, 
1
J = 273.0 Hz, CCF3); 
19
F NMR 
(376 MHz, DMSO-d6) δ (ppm) = -61.3 (s, 6F); MS (ASAP): m/z 
513.0 [MH
+
]. Calcd. for C18H8F12N2O2H
+
: 513.0; Anal. Calcd. 
for C18H8F12N2O2: C, 42.21; H, 1.57; N, 5.47. Found:  C, 42.16; 
H, 1.57; N, 5.57.  
 
General procedure for the synthesis of dibenzoylhydrazide-
bridged diiridium complexes. IrCl3·3H2O (1.00 eq.) and the 
cyclometalating ligand (2.20 eq.) were added to 2-ethoxyethanol 
(5 mL per 200 mg IrCl3·3H2O) and the mixture was heated to 
reflux under an argon atmosphere for 24 h to form the dichloro-
bridged diiridium intermediate in situ. The reaction mixture was 
then cooled to room temperature before addition of the bridging 
ligand (0.50 eq.) and K2CO3 (5.00 eq.). The mixture was then 
heated at reflux for a further 24 h before being cooled to room 
temperature and diluted with water (ca. 70 mL per 200 mg 
IrCl3·3H2O) to yield a colored precipitate, which was isolated 
via filtration and washed with water (2 × 50 mL). 
 
Complexes 13a + b. Following the general procedure,  
IrCl3·3H2O (400 mg, 1.13 mmol, 1.00 eq.), N-phenylpyrazole (7) 
(360 mg, 2.50 mmol, 2.21 eq.), N,Nʹ-bis(4-tert-
butylbenzoyl)hydrazide (11) (200 mg, 0.57 mmol, 0.50 eq.) and 
K2CO3 (780 mg, 5.64 mmol, 4.99 eq.) gave a brown precipitate. 
The isolated solid was triturated with boiling n-hexane (500 
mL). The hexane insoluble material was passed through a neutral 
alumina plug (eluent: DCM sat. K2CO3) and purified by frac-
tional crystallization via liquid diffusion from saturated DCM 
solutions layered with n-hexane. This yielded the meso isomer 
(13a) as pale green crystals (172 mg, 0.12 mmol, 21%). 
1
H NMR 
(700 MHz, CDCl3) δ 7.97 (d, J = 2.8 Hz, 2HA3), 7.94 (d, J = 2.0 
Hz, 2HA5), 7.90 (d, J = 2.9 Hz, 2HB3), 7.60 (d, J = 2.1 Hz, 2HB5), 
6.94 (d, J = 7.8 Hz, 2HB11), 6.77 (t, J = 2.5 Hz, 2HA4), 6.72 (d, J 
= 7.8 Hz, 2HA11), 6.63 (t, J = 7.4 Hz, 2HB10), 6.58 (d, J = 8.1 Hz, 
4HC3), 6.53 (t, J = 2.5 Hz, 2HB4), 6.45 (t, J = 7.4 Hz, 4HA10/B9), 
6.38 (d, J = 7.9 Hz, 4HC2), 6.13 (t, J = 7.5 Hz, 2HA9), 5.98 (dd, J 
= 7.7, 1.3 Hz, 2HB8), 5.54 (d, J = 7.4 Hz 2HA8), 1.10 (s, 18Ht-Bu); 
MS (MALDI–TOF): m/z 1308.4 [M+]. Calcd. for 
C58H54Ir2N10O2
+
: 1308.4; Anal. Calcd. for C58H54Ir2N10O2: C, 
53.28; H, 4.16; N, 10.71. Found:  C, 53.19; H, 4.15; N, 10.69. 
The filtrate from the trituration was mixed with celite (ca. 2 g) 
under reduced pressure and subjected to flash chromatography 
on silica gel (eluent: gradient n-hexane/ DCM sat. K2CO3 1:0–
1:9 v/v) to yield the crude rac isomer (13b), which eluted before 
residual traces of the meso isomer. Trituration with hot methanol 
followed by filtration gave 13b as a pale green powder (90 mg, 
0.07 mmol, 12%). 
1
H NMR (700 MHz, CDCl3) δ (ppm) = 8.02 
(dd, J = 2.9, 0.7 Hz, 2HC3), 8.01 (dd, J = 3.0, 0.7 Hz, 2HA3), 7.75 
(dd, J = 2.1, 0.7 Hz, 2HA5), 7.37 (dd, J = 2.1, 0.7 Hz, 2HC5), 7.03 
(dd, J = 7.9, 1.1 Hz, 2HB3), 6.85 (dd, J = 7.8, 1.2 Hz, 2HD3), 6.69 
(ddd, J = 7.9, 7.2, 1.3 Hz, 2HB4), 6.65–6.57 (m, 12HA4, C4, E2, E3), 
6.49–6.45  (m, 4HD4, B5), 6.03 (td, J = 7.4, 1.2 Hz, 2HD5), 5.98 
(dd, J = 7.6, 1.3 Hz, 2HB6), 5.32 (dd, J = 7.6, 1.3 Hz, 2HD6), 1.10 
(s, 18Ht-Bu); 
13
C NMR (176 MHz, CDCl3) δ (ppm) = 176.1 
(CC=O), 149.4 (CE1), 143.5 (CB1), 142.4 (CD1), 137.7 (CA5), 136.6 
(CC5), 134.4 (CB6), 133.6 (CD6), 133.4 (CE4), 133.3 (CB2), 133.0 
(CB2), 126.6 (CA3), 125.5 (CE2), 125.2 (CD5), 124.6 (CC3), 123.9 
(CE3), 121.2 (CB4), 119.4 (CD4), 110.3 (CB3), 109.6 (CD3), 106.6 
(CA4), 106.3 (CC4), 34.2 (Ct-Bu quart), 31.2 (Ct-Bu Me); MS (MALDI–
TOF): m/z 1308.4 [M
+
]. Calcd. for C58H54Ir2N10O2
+
: 1308.4; 
Anal. Calcd. for C58H54Ir2N10O2: C, 53.28; H, 4.16; N, 10.71. 
Found:  C, 53.56; H, 4.36; N, 10.49. 
Solutions sufficiently concentrated for full assignment of carbon 
environments and C^N ligand orientation with respect to the 
bridge could not be obtained for 13a due to its low solubility in 
organic solvents. 
  
 
 
Complexes 14a + b. Following the general procedure,  
IrCl3·3H2O (340 mg, 0.96 mmol, 1.00 eq.), N-(2,4-
difluorophenyl)pyrazole (8) (380 mg, 2.11 mmol, 2.20 eq.), 
N,Nʹ-bis(4-tert-butylbenzoyl)hydrazide (11) (170 mg, 0.48 
mmol, 0.50 eq.) and K2CO3 (665 mg, 4.81 mmol, 5.01 eq.) gave 
an off-white precipitate. The isolated solid was triturated with 
boiling n-hexane (300 mL). The hexane insoluble material was 
passed through a neutral alumina plug (eluent: DCM sat. K2CO3) 
and purified by fractional crystallization via liquid diffusion 
from saturated DCM solutions layered with n-hexane. This 
yielded the meso isomer (14a) as white crystals (130 mg, 0.09 
mmol, 19%). 
1
H NMR (700 MHz, CDCl3) δ (ppm) = 8.31 (d, J = 
2.9 Hz, 2HA3), 8.22 (d, J = 3.0 Hz, 2HC3), 7.92 (d, J = 2.1 Hz, 
2HA5), 7.54 (d, J = 2.2 Hz, 2HC5), 6.86 (dd, J = 3.0, 2.2 Hz, 
2HA4), 6.78 (d, J = 8.7 Hz, 4HE3), 6.60 (dd, J = 3.0, 2.2 Hz, 
2HC4), 6.39 (d, J = 7.7 Hz, 4HE2), 6.29 (ddd, J = 11.5, 8.6, 2.5 
Hz, 2HD4), 6.07 (ddd, J = 11.4, 8.6, 2.5 Hz, 2HB4), 5.40 (dd, J = 
8.5, 2.5 Hz, 2HD6), 5.00 (dd, J = 8.7, 2.5 Hz, 2HB6), 1.14 (s, 
18Ht-Bu); 
13
C NMR (176 MHz, CDCl3) δ (ppm) = 176.7 (CC=O), 
159.6 (dd, J = 250.00, 10.51 Hz, CD5), 159.0 (dd, J = 248.64, 
11.28 Hz, CB5) 150.2 (CE1), 148.6 (dd, J = 253.03, 12.73 Hz, 
CD3), 148.0 (dd, J = 251.38, 13.68 Hz, CB3), 136.9 (CC5), 136.2 
(CA5), 132.4 (CE4), 130.6 (d, J = 15.0 Hz, CC3), 130.2 (d, J = 14.6 
Hz, CA3), 127.5 (CD2), 126.5 (CB2), 126.03 (CE2), 124.00 (CE3), 
115.8 (d, J = 18.8 Hz, CD1), 115.2 (d, J = 18.7 Hz, CB1), 107.4 
(d, J = 2.5 Hz, CA4), 107.3 (d, J = 2.5 Hz, CC4), 97.8 (dd, J = 
28.2, 23.4 Hz, CD4), 96.4 (dd, J = 28.1, 23.0 Hz, CB4), 34.3 (Ct-Bu 
quart), 31.0 (Ct-Bu Me); 
19
F NMR (376 MHz, CDCl3) δ -114.5 – -
114.4 (m, 4F), -125.8 (dd, J = 12.0, 5.5 Hz, 2F), -126.01 (dd, J = 
11.9, 5.3 Hz, 2F); MS (MALDI–TOF): m/z 1452.3 [M+]. Calcd. 
for C58H46F8Ir2N10O2
+
: 1452.3; Anal. Calcd. for 
C58H46F8Ir2N10O2: C, 47.99; H, 3.19; N, 9.65. Found:  C, 47.92; 
H, 3.20; N, 9.62. The filtrate from the trituration was mixed with 
celite (ca. 2 g) under reduced pressure and subjected to flash 
chromatography on silica gel (eluent: gradient n-hexane/DCM 
sat. K2CO3 1:0–2:3 v/v) to yield the crude rac isomer (14b), 
which eluted before residual traces of the meso isomer. Tritura-
tion with hot methanol followed by filtration gave 14b as a white 
powder (105 mg, 0.07 mmol, 15%) 
1
H NMR (700 MHz, CDCl3) 
δ (ppm) = 8.33 (d, J = 3.0 Hz ,2HA3), 8.32 (d, J = 2.9 Hz, 2HC3), 
7.76 (dd, J = 2.1, 0.7 Hz, 2HA5), 7.32 (dd, J = 2.1, 0.6 Hz, 2HC5), 
6.81 (d, J = 8.4 Hz, 4HE3), 6.72 (dd, J = 3.0, 2.2 Hz, 2HA4), 6.67 
(dd, J = 2.9, 2.2 Hz, 2HC4), 6.58 (d, J = 7.8 Hz, 4HE2), 6.33 (ddd, 
J = 11.5, 8.6, 2.5 Hz, 2HB4), 6.07 (ddd, J = 11.4, 8.6, 2.5 Hz, 
2HD4), 5.42 (dd, J = 8.4, 2.5 Hz, 2HB6), 4.81 (dd, J = 8.8, 2.4 Hz, 
2HD6), 1.14 (s, 18Ht-Bu); 
13
C NMR (176 MHz, CDCl3) δ (ppm) = 
176.4 (CC=O), 159.6 (dd, J = 250.83, 11.15 Hz, CB5), 158.8 (dd, J 
= 247.73, 12.08 Hz, CD5), 150.7 (CE1), 148.6 (dd, J = 251.19, 
11.51 Hz, CB3), 148.0 (dd, J = 251.19, 13.10 Hz, CD3), 137.3 
(CA5), 136.3 (CC5), 132.5 (CE4), 130.7 (d, J = 14.9 Hz, CA3), 
129.9 (d, J = 14.9 Hz, CC3), 127.5 (CB1), 126.6 (CD1), 126.5 
(CE2), 124.1 (CE3), 116.0 (d, J = 19.5 Hz, CB2), 115.1 (d, J = 20.3 
Hz, CD2), 107.6 (d, J = 2.5 Hz, CA4), 107.1 (d, J = 2.5 Hz, CC4), 
97.8 (dd, J = 27.9, 23.4 Hz, CB4), 96.3 (dd, J = 28.2, 23.3 Hz, 
CD4), 34.3 (Ct-Bu quart), 31.0 (Ct-Bu Me); 
19
F NMR (376 MHz, 
CDCl3) δ (ppm) = -114.3 – -114.2 (m, 4F), -125.8 (dd, J = 12.0, 
5.5 Hz, 2F), -126.8 (dd, J = 12.0, 5.2 Hz, 2F); MS (MALDI–
TOF): m/z 1452.3 [M
+
]. Calcd. for C58H46F8Ir2N10O2
+
: 1452.3; 
Anal. Calcd. for C58H46F8Ir2N10O2: C, 47.99; H, 3.19; N, 9.65, 
Calcd. for C58H46F8Ir2N10O2•0.1C6H14 (C6H14 is observed in 
1
H 
NMR, Figure S21): C, 48.20; H, 3.27; N, 9.59. Found:  C, 48.44; 
H, 3.35; N, 9.46. 
 
 
 
Complexes 15a + b. Following the general procedure, 
IrCl3·3H2O (200 mg, 0.57 mmol, 1.00 eq.), 2-(2-fluoro-4-
methoxyphenyl)pyridine (10) (255 mg, 1.25 mmol, 2.19 eq.), 
N,N’-bis(4-tert-butylbenzoyl)hydrazide (11) (100 mg, 0.28 
mmol, 0.50 eq.) and K2CO3 (390 mg, 2.82 mmol, 4.95 eq.) gave 
a yellow precipitate. The isolated solid was extracted into DCM 
sat. K2CO3 (ca. 100 mL) and suspended onto celite (ca. 2 g) 
under reduced pressure. The residue was purified via flash 
chromatography on silica gel (eluent: gradient n-hexane/ DCM 
sat. K2CO3 1:0–3:7 v/v). First to elute was the rac isomer (15b), 
followed by the meso isomer (15a). Final purification by tritura-
tion with hot methanol gave the diastereomers as yellow pow-
ders:  
 rac (15b) (58 mg, 0.04 mmol, 13%). 
1
H NMR (700 MHz, CDCl3) δ 
(ppm) = 9.17 (dd, J = 5.2, 1.3 Hz, 2HA6), 8.24 (d, J = 5.4 Hz, 2HC6), 
8.13 (d, J = 8.5 Hz, 2HA3), 7.98 (d, J = 8.4 Hz, 2HC3), 7.77 (td, J = 
7.9, 1.6 Hz, 2HA4), 7.74 – 7.71 (m, 2HC4), 7.21 (ddd, J = 7.2, 5.5, 1.4 
Hz, 2HA5), 6.93 (ddd, J = 7.2, 5.5, 1.4 Hz, 2HC5), 6.67 (d, J = 8.4 Hz, 
4HE3), 6.47 (d, J = 8.4 Hz, 4HE2), 5.98 (dd, J = 14.3, 2.3 Hz, 2HB4), 
5.78 (dd, J = 14.0, 2.3 Hz, 2HD4), 5.21 (d, J = 2.3 Hz, 2HB6), 5.05 (d, J 
= 2.3 Hz, 2HD6), 3.38 (s, 6HMeO-B), 3.36 (s, 6HMeO-D), 1.12 (s, 18Ht-Bu 
Me); 
13
C NMR (176 MHz, CDCl3) δ (ppm) = 176.2 (CC=O), 166.9 (d, J 
= 6.85 Hz, CA2), 166.4 (d, J = 5.68 Hz, CC2), 161.6 (d, J = 255.91 Hz, 
CB3), 161.2 (d, J = 256.71 Hz, CD3), 160.8 (d, J = 11.28 Hz, CD5), 
160.1 (d, J = 11.82 Hz, CB5), 149.7 (CE1), 148.9 (CA6), 147.5 (CC6), 
137.2 (CA4), 136.4 (CC4), 132.4 (CE4), 126.6 (CE2), 124.5 (d, J = 4.85 
Hz, CB1), 123.6 (CE3), 123.5 (d, J = 4.85 Hz, CD1), 122.5 (d, J = 17.65 
Hz, CA3), 121.4 (d, J = 18.69 Hz, CC3), 120.0 (CA5), 119.5 (CC5), 112.9 
(CB6), 111.6 (CD6), 95.0 (d, J = 27.69 Hz, CB4), 94.1 (d, J = 26.31 Hz, 
CD4), 54.7 (COMe-D), 54.4 (COMe-B), 34.2 (Ct-Bu quart), 31.0 (Ct-Bu Me); 
19
F 
NMR (376 MHz, CDCl3) δ (ppm) = -112.7 (d, J = 14.5 Hz, 2F), -
113.1 (d, J = 14.2 Hz, 2F); MS (MALDI–TOF): m/z 1544.4 [M+]. 
Calcd. for C70H62F4Ir2N6O6
+
: 1544.4; Anal. Calcd. for 
C70H62F4Ir2N6O6: C, 54.46; H, 4.05; N, 5.44. Found:  C, 54.35; H, 
4.22; N, 5.12. 
meso (15a) (90 mg, 0.06 mmol, 20%). 
1
H NMR (700 MHz, 
CDCl3) δ (ppm) = 9.00 (d, J = 5.3 Hz, 2HA6/C6), 8.75 (d, J = 5.3 
Hz, 2HA6/C6), 8.10 – 8.06 (m, 4HA3/C3), 7.84 (t, J = 7.6 Hz, 
2HA4/C4), 7.67 (t, J = 7.9 Hz, 2HA4/C4), 7.30 (t, J = 6.7 Hz, 
2HA5/C5), 6.88 (t, J = 6.7 Hz, 2HA5/C5), 6.70 (d, J = 7.9 Hz, 4HE3), 
6.35 (d, J = 7.8 Hz, 4HE2), 6.01 (dd, J = 14.5, 2.3 Hz, 2HB4), 5.81 
(dd, J = 14.2, 2.3 Hz, 2HD4), 5.29 (d, J = 2.3 Hz, 2HB6), 5.08 (d, 
J = 2.3 Hz, 2HD6), 3.42 (s, 6HMeO B), 3.38 (s, 6HMeO D), 1.16 (s, 
18Ht-Bu); 
19
F NMR (376 MHz, CD2Cl2 ) δ (ppm) = -112.8 (d, J = 
16.9 Hz, 2F), -113.3 (d, J = 16.5 Hz, 2f); MS (MALDI–TOF): 
m/z 1544.4 [M
+
]. Calcd. for C70H62F4Ir2N6O6
+
: 1544.4; Anal. 
Calcd. for C70H62F4Ir2N6O6: C, 54.46; H, 4.05; N, 5.44. Found:  
C, 54.56; H, 4.15; N, 5.33. 
Solutions sufficiently concentrated for full assignment of carbon 
environments and ligand pyridine–phenyl connectivity could not 
be obtained for 15a due to its low solubility in organic solvents. 
 
 
Complexes 16a + b. Following a modification of the general 
procedure starting directly from the dichloro-bridged intermedi-
ate [Ir(ppy)2µ–Cl]2 (400 mg, 0.37 mmol, 1.00 eq.) N,Nʹ-bis(3,5-
bis(trifluoromethyl)benzoyl)hydrazide (12) (191 mg, 0.37 mmol, 
1.00 eq.) and K2CO3 (258 mg, 1.87 mmol, 5.00 eq.) a yellow 
precipitate was obtained. The isolated solid was then extracted 
into DCM sat. K2CO3 (ca. 100 mL) and mixed with celite (ca. 2 
g) under reduced pressure. The residue was purified via flash 
chromatography on silica gel (eluent: n-hexane/ DCM sat. 
K2CO3 1:1) and both diastereomers were collected as a single 
fraction. After evaporation of the solvent under reduced pres-
sure, the yellow residue was refluxed in toluene (ca. 600 mL) for 
10 min before being filtered hot through a glass sinter. The fil-
trate was then reduced in volume by ca. 50 mL and filtered again 
while hot. This process of reducing the volume by 50 mL fol-
lowed by hot filtration was repeated a further two times before 
all of the isolated solids were combined and washed with pen-
tane to afford the meso isomer (16a) (78 mg, 0.05 mmol, 14%) 
as a yellow powder. 
1
H NMR (700 MHz, CD2Cl2) δ (ppm) = 
9.01 (dd, J = 5.5, 1.3 Hz, 2HA6), 8.76 (dd, J = 5.6 Hz, 2HB6), 
7.98 – 7.94 (m, 2HA4), 7.84 – 7.78 (m, 6HA3,B3.B4), 7.53 (ddd, J = 
7.2, 5.5, 1.4 Hz, 2HA5), 7.47 (bs, 2HC2 or 6), 7.43 (dd, J = 7.7, 1.3 
Hz, 2HB9), 7.27 (s, 2HC4), 7.16 – 7.09 (m, 4HA9,B5), 6.75 (t, J = 
7.0 Hz, 2HB10), 6.59 (ddd, J = 8.2, 7.0, 1.3 Hz, 2HB11), 6.48 (td, J 
= 7.4, 1.2 Hz, 2HA10), 6.30 (t, J = 7.3 Hz, 2HA11), 6.01 (bs, 2HC2 
or 6), 5.92 (dd, J = 8.2, 1.2 Hz, 2HB12), 5.85 (dd, J = 7.7, 1.1 Hz, 
2HA12); 
19
F NMR (376 MHz, CD2Cl2) δ (ppm) = -63.07 (bs, 6F), 
-63.18 (bs, 6F); MS (MALDI–TOF): m/z 1512.2 [M+]. Calcd. for 
C62H38F12Ir2N6O2
+
: 1512.2; Anal. Calcd. for C62H38F12Ir2N6O2: 
C, 49.27; H, 2.53; N, 5.56. Found:  C, 49.04; H, 2.55; N, 5.47. 
The filtrate from the hot filtrations was mixed with celite (ca. 2 
g) under reduced pressure before being subjected to flash chro-
matography on silica gel (eluent: gradient n-hexane/ DCM sat. 
K2CO3 1:0–1:1 v/v) to yield the crude rac isomer (16b), which 
eluted before residual meso isomer. The residue was triturated 
with boiling methanol (ca. 5 mL) and the resulting suspension 
was cooled in a fridge before being filtered and washed with 
pentane to afford 16b as a yellow powder (56 mg, 0.04 mmol, 
10%). 
1
H NMR (700 MHz, CD2Cl2) δ (ppm) =  9.24 (dd, J = 5.5, 
1.4 Hz, 2HA6), 8.28 (d, 5.2 Hz, 2HB6), 7.96 – 7.91 (m, 4HA4,B4), 
7.89 (d, J = 8.3 Hz, 2HA3), 7.75 (d, J = 8.1 Hz, 2HB3), 7.50 (ddd, 
J = 7.3, 5.6, 1.5 Hz, 2HA5), 7.47 (d, J = 7.7 Hz, 2HA9), 7.28 – 
7.25 (m, 4HB5,C4), 7.09 (dd, J = 7.6, 1.3 Hz, 2HB9), 7.08 (bs, 2HC2 
or 6), 6.81 (bs, 2HC2 or 6), 6.76 (t, J = 7.5 Hz, 2HA10), 6.58 (t, J = 
8.3 Hz, 2HA11), 6.50 (t, J = 7.4 Hz, 2HB10), 6.36 (t, J = 7.4 Hz, 
2HB11), 5.90 (dd, J = 7.7, 1.2 Hz, 2HA12), 5.85 (dd, J = 7.7, 1.1 
Hz, 2HB12); 
19
F NMR (376 MHz, CD2Cl2) δ (ppm) = -62.8 (bs, 
6F), -63.2 (bs, 6F); MS (MALDI–TOF): m/z 1512.2 [M+]. Calcd. 
for C62H38F12Ir2N6O2
+
: 1512.2; Anal. Calcd. for 
C62H38F12Ir2N6O2: C, 49.27; H, 2.53; N, 5.56. Found:  C, 48.94; 
H, 2.65; N, 5.43. Solutions sufficiently concentrated for full 
assignment of carbon environments could not be obtained for 
either complex due to low solubility in organic solvents. 
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